The activation of the PAM signaling pathway enhances the immunosuppressive functions of MDSCs, leading to increased secretion of inhibitory cytokines, such as IL-6 and TGF-β, which suppress the anti-tumor activity of effector immune cells. This evidence concerns the gene IL6 and neoplasm.